Double-Coated Metal Nanoparticles for MRI Contrast Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current metal-based nanoparticles for biomedical applications face challenges in achieving precise size control and low toxicity, with existing synthesis methods often compromising on yield and stability, which is critical for applications like MRI contrast agents where size and toxicity impact efficacy and safety.
Innovation Solution
A method for synthesizing metal-based nanoparticles with a transition metal core, featuring a first siloxane-based coating layer to prevent oxidation and a second functional coating layer for enhanced hydrophilicity and specific properties, allowing for controlled size and reduced toxicity, thereby improving their stability and performance in biomedical applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If metal-based nanoparticles are synthesized for biomedical applications, then they exhibit unique optical and electrical properties, but they face challenges in achieving precise size control and low toxicity
Solution Approach 1:
The nanoparticle structure is segmented into a metal core and a separate coating layer. The coating layer acts as an independent protective segment that reduces toxicity without interfering with the core metal's optical and electrical properties, while also enabling precise size control through controlled coating thickness
Solution Approach 2:
The coating layer serves as an intermediary between the metal core and the biological environment. It mediates the interaction by reducing toxicity toward biological systems while maintaining the desired size for biomedical applications, thus resolving the contradiction between toxicity control and size precision
2Reliability
If existing synthesis methods are used to produce metal-based nanoparticles, then production yield is achieved, but stability is compromised
Solution Approach 1:
The invention creates a composite nanoparticle consisting of a metal core combined with a coating layer material. This composite structure enhances stability by protecting the metal core from oxidation and aggregation, while the synthesis method is optimized to maintain high yield through efficient coating formation without requiring complex additional steps
3Measurement precision
If metal nanoparticles are used for MRI contrast agents, then contrast enhancement is achieved, but size and toxicity impact efficacy and safety
Solution Approach 1:
The coating layer acts as an intermediary that reduces the harmful toxic effects of the metal nanoparticle on biological tissue while allowing the nanoparticle to maintain its contrast-enhancing properties. The coating enables safe interaction with the biological environment during MRI procedures
Solution Approach 2:
The coating layer provides localized protection at the surface of the nanoparticle, creating a region of low toxicity that interfaces with biological systems, while the internal metal core maintains its high contrast enhancement capability. This local differentiation resolves the contradiction between efficacy and safety
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach results in nanoparticles with improved stability, reduced toxicity, and enhanced performance for MRI applications, enabling better contrast enhancement and safety profiles, while allowing for targeted delivery and imaging.
Implementation Method 1
a first siloxane-based coating layer to prevent oxidation
Implementation Method 2
a second functional coating layer for enhanced hydrophilicity
Data Source
AI summary
A nanoparticle includes a metal-based core, a first coating layer substantially covering the metal-based core to generate a coated metal-based core, and a second coating layer at least partially covering the coated metal-based core, wherein the metal-based core comprises at least one transition metal, and wherein the metal-based core comprises the at least one transition metal substantially in a state of zero oxidation.